ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II study of gemcitabine in patients with advanced pancreatic cancer
British Journal of Cancer
◽
10.1038/bjc.1996.18
◽
1996
◽
Vol 73
(1)
◽
pp. 101-105
◽
Cited By ~ 232
Author(s):
J Carmichael
◽
U Fink
◽
RC Russell
◽
MF Spittle
◽
AL Harris
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718415927.793495708
◽
2014
◽
Author(s):
Alexandru Grigorescu
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Gemcitabine Refractory
Download Full-text
Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer
Oncology
◽
10.1159/000206141
◽
2009
◽
Vol 76
(4)
◽
pp. 270-274
◽
Cited By ~ 19
Author(s):
Joanna M. Brell
◽
Khalid Matin
◽
Terry Evans
◽
Robert L. Volkin
◽
Gauri J. Kiefer
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Pretreated Patients
Download Full-text
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-012-1875-1
◽
2012
◽
Vol 69
(6)
◽
pp. 1641-1645
◽
Cited By ~ 41
Author(s):
Alberto Zaniboni
◽
Enrico Aitini
◽
Sandro Barni
◽
Daris Ferrari
◽
Stefano Cascinu
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Second Line
◽
Second Line Chemotherapy
◽
Multicenter Phase
◽
Line Chemotherapy
Download Full-text
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-012-1822-1
◽
2012
◽
Vol 69
(5)
◽
pp. 1197-1204
◽
Cited By ~ 61
Author(s):
Masato Ozaka
◽
Yuji Matsumura
◽
Hiroshi Ishii
◽
Yasushi Omuro
◽
Takao Itoi
◽
...
Keyword(s):
Pancreatic Cancer
◽
Cancer Research
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Research Organization
◽
Clinical Cancer Research
◽
Clinical Cancer
◽
Randomized Phase Ii
Download Full-text
Resection of locally advanced pancreatic cancer after neoadjuvant chemotherapy with modified FOLFIRINOX: A prospective phase II study
Pancreatology
◽
10.1016/j.pan.2013.04.310
◽
2013
◽
Vol 13
(3)
◽
pp. S88-S89
Author(s):
Nelide De Lio
◽
Enrico Vasile
◽
Mario Antonio Belluomini
◽
Francesca Costa
◽
Carla Cappelli
◽
...
Keyword(s):
Pancreatic Cancer
◽
Neoadjuvant Chemotherapy
◽
Phase Ii
◽
Phase Ii Study
◽
Locally Advanced
◽
Advanced Pancreatic Cancer
◽
Locally Advanced Pancreatic Cancer
◽
Prospective Phase
Download Full-text
Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study
Oncology
◽
10.1159/000074474
◽
2003
◽
Vol 65
(3)
◽
pp. 218-223
◽
Cited By ~ 28
Author(s):
Bryan P. Schneider
◽
Kristen N. Ganjoo
◽
David E. Seitz
◽
Joel Picus
◽
Farid Fata
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic Cancer
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2007.01.005
◽
2007
◽
Vol 68
(3)
◽
pp. 809-816
◽
Cited By ~ 86
Author(s):
Andrew H. Ko
◽
Jeanne M. Quivey
◽
Alan P. Venook
◽
Emily K. Bergsland
◽
Elizabeth Dito
◽
...
Keyword(s):
Pancreatic Cancer
◽
Dose Rate
◽
Phase Ii
◽
Low Dose
◽
Phase Ii Study
◽
Locally Advanced
◽
Advanced Pancreatic Cancer
◽
Locally Advanced Pancreatic Cancer
◽
Fixed Dose
◽
Fixed Dose Rate
Download Full-text
GEMOX plus hypofractionated radiotherapy for unresectable locally advanced pancreatic cancer: Results from a phase II study
Annals of Oncology
◽
10.1093/annonc/mdy282.115
◽
2018
◽
Vol 29
◽
pp. viii249
Author(s):
A. Passardi
◽
E. Scarpi
◽
E. Neri
◽
E. Parisi
◽
G. Ghigi
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Locally Advanced
◽
Advanced Pancreatic Cancer
◽
Locally Advanced Pancreatic Cancer
◽
Hypofractionated Radiotherapy
Download Full-text
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer
Journal of Experimental & Clinical Cancer Research
◽
10.1186/s13046-017-0509-1
◽
2017
◽
Vol 36
(1)
◽
Cited By ~ 9
Author(s):
Yoshitaro Shindo
◽
Shoichi Hazama
◽
Nobuaki Suzuki
◽
Haruo Iguchi
◽
Kazuhiro Uesugi
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Peptide Vaccine
◽
Advanced Pancreatic Cancer
◽
Predictive Biomarkers
◽
Vaccine Treatment
Download Full-text
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-008-0873-9
◽
2008
◽
Vol 64
(2)
◽
pp. 317-325
◽
Cited By ~ 11
Author(s):
Kyung Hee Lee
◽
Min Kyoung Kim
◽
Yeol Hong Kim
◽
Baek Yeol Ryoo
◽
Ho Yeong Lim
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Line Treatment
◽
First Line
◽
Multicenter Phase
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close